US medical devices industry saw a drop of 35.37% in overall deal activity during January 2021, when compared with the last 12-month average, led by OptumInsight’s $13bn acquisition of Change Healthcare, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 53 deals worth $22.2bn were announced in January 2021, compared with the 12-month average of 82 deals.
M&A was the leading category in the month in terms of volume with 25 deals, which accounted for 47.2% of all deals.
In second place was venture financing with 24 deals, followed by private equity with four transactions, respectively accounting for 45.3% and 7.6% of overall deal activity in the US technology industry during the month.
In terms of value of deals, M&A was the leading deal category in the US medical devices industry with total deals worth $21.21bn, while venture financing and private equity deals totalled $929.33m and $64m respectively.
US medical devices industry deals in January 2021: Top deals
The top five medical devices industry deals accounted for 90.1% of the overall value during January 2021.
The combined value of the top five medical devices deals stood at $20.01bn, against the overall value of $22.2bn recorded for the month.
The top five medical devices industry deals of January 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’s $1.23bn acquisition of Preventice
4) The $635m acquisition deal with Capsule Technologies by Koninklijke Philips
5) Thermo Fisher Scientific’s acquisition of Mesa Biotech for $550m.